In last trading session, Health Catalyst Inc (NASDAQ:HCAT) saw 0.38 million shares changing hands with its beta currently measuring 1.56. Company’s recent per share price level of $4.06 trading at -$0.05 or -1.22% at ring of the bell on the day assigns it a market valuation of $282.58M. That closing price of HCAT’s stock is at a discount of -127.59% from its 52-week high price of $9.24 and is indicating a premium of 12.32% from its 52-week low price of $3.56. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.6 million shares which gives us an average trading volume of 729.41K if we extend that period to 3-months.
For Health Catalyst Inc (HCAT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.62. Splitting up the data highlights that, out of 11 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 8 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Health Catalyst Inc (NASDAQ:HCAT) trade information
Upright in the red during last session for losing -1.22%, in the last five days HCAT remained trading in the red while hitting it’s week-highest on Tuesday, 05/13/25 when the stock touched $4.06 price level, adding 14.35% to its value on the day. Health Catalyst Inc’s shares saw a change of -42.57% in year-to-date performance and have moved -1.69% in past 5-day. Health Catalyst Inc (NASDAQ:HCAT) showed a performance of 8.27% in past 30-days. Number of shares sold short was 3.14 million shares which calculate 5.46 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 18.8% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 7. It follows that stock’s current price would drop -23.15% in reaching the projected high whereas dropping to the targeted low would mean a loss of -23.15% for stock’s current value.
Health Catalyst Inc (HCAT) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 38.24% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -9.64% while estimates for its earnings growth in next 5 years are of 34.32%.
Health Catalyst Inc (NASDAQ:HCAT)’s Major holders
Insiders are in possession of 3.71% of company’s total shares while institution are holding 81.14 percent of that, with stock having share float percentage of 84.27%. Investors also watch the number of corporate investors in a company very closely, which is 81.14% institutions for Health Catalyst Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at HCAT for having 5.43 million shares of worth $34.72 million. And as of 2024-06-30, it was holding 9.1608 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.53 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.6335 of outstanding shares, having a total worth of $28.93 million.
On the other hand, IMPAX FUNDS SERIES TRUST I-Impax Small Cap Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 2.75 shares of worth $11.16 million or 3.95% of the total outstanding shares. The later fund manager was in possession of 1.81 shares on Dec 31, 2024 , making its stake of worth around $7.34 million in the company or a holder of 2.60% of company’s stock.
